Se Weon Park

Ms. Se Weon Park

City University of Hong Kong
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JHJianpan Huang
Jianpan Huang
ZCZilin Chen
Zilin Chen
SPSe Weon Park
Se Weon Park
HLHo Chi Joseph Lai
Ho Chi Joseph Lai
Kannie WY ChanKannie WY Chan
Kannie WY Chan
Chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) detects molecules in their natural forms in a sensitive and non-invasive manner. This makes it a robust approach to assess brain tumors and related molecular alterations using endogenous molecules, such as proteins/peptides, and drugs approved for clinical use. In this review, we will discuss the promises of CEST MRI in the identification of tumors, tumor grading, detecting molecular alterations related to isocitrate dehydrogenase (IDH) and O-6-methylguanine-DNA methyltransferase (MGMT), assessment of treatment effects, and using multiple contrasts of CEST to develop theranostic approaches for cancer treatments. Promising applications include (i) using the CEST contrast of amide protons of proteins/peptides to detect brain tumors, such as glioblastoma multiforme (GBM) and low-grade gliomas; (ii) using multiple CEST contrasts for tumor stratification, and (iii) evaluation of the efficacy of drug delivery without the need of metallic or radioactive labels. These promising applications have raised enthusiasm, however, the use of CEST MRI is not trivial. CEST contrast depends on the pulse sequences, saturation parameters, methods used to analyze the CEST spectrum (i.e., Z-spectrum), and, importantly, how to interpret changes in CEST contrast and related molecular alterations in the brain. Emerging pulse sequence designs and data analysis approaches, including those assisted with deep learning, have enhanced the capability of CEST MRI in detecting molecules in brain tumors. CEST has become a specific marker for tumor grading and has the potential for prognosis and theranostics in brain tumors. With increasing understanding of the technical aspects and associated molecular alterations detected by CEST MRI, this young field is expected to have wide clinical applications in the near future.

2 June 2021 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
XHXiongqi Han
Xiongqi Han
JLJoseph Ho Chi Lai
Joseph Ho Chi Lai
JHJianpan Huang
Jianpan Huang
SPSe Weon Park
Se Weon Park
YLYang Liu
Yang Liu
Kannie WY ChanKannie WY Chan
Kannie WY Chan

12 January 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SPSe Weon Park
Se Weon Park
HLHo Chi Joseph Lai
Ho Chi Joseph Lai
XHXiongqi Han
Xiongqi Han
VLVivian W. M. Leung
Vivian W. M. Leung
PXPeng Xiao
Peng Xiao
Kannie WY ChanKannie WY Chan
Kannie WY Chan
Treating glioblastoma and monitoring treatment response non-invasively remain challenging. Here, we developed a robust approach using a drug-loaded liposomal hydrogel that is mechanically compatible with the brain, and, simultaneously, we successfully monitored early tumor response using Chemical Exchange Saturation Transfer (CEST) MRI. This CEST-detectable liposomal hydrogel was optimized based on a sustainable drug release and a soft hydrogel for the brain tumor, which is unfavorable for tumor cell proliferation. After injecting the hydrogel next to the tumor, three distinctive CEST contrasts enabled the monitoring of tumor response and drug release longitudinally at 3T. As a result, a continuous tumor volume decrease was observed in the treatment group along with a significant decrease in CEST contrasts relating to the tumor response at 3.5 ppm (Amide Proton Transfer; APT) and at −3.5 ppm (relayed Nuclear Overhauser Effect; rNOE) when compared to the control group (p < 0.05). Interestingly, the molecular change at 3.5 ppm on day 3 (p < 0.05) was found to be prior to the significant decrease in tumor volume on day 5. An APT signal also showed a strong correlation with the number of proliferating cells in the tumors. This demonstrated that APT detected a distinctive decrease in mobile proteins and peptides in tumors before the change in tumor morphology. Moreover, the APT signal showed a regional response to the treatment, associated with proliferating and apoptotic cells, which allowed an in-depth evaluation and prediction of the tumor treatment response. This newly developed liposomal hydrogel allows image-guided brain tumor treatment to address clinical needs using CEST MRI.

28 May 2025 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
CCChu Chen
Chu Chen
YLYang Liu
Yang Liu
SPSe Weon Park
Se Weon Park
JLJizhou Li
Jizhou Li
Kannie WY ChanKannie WY Chan
Kannie WY Chan
Raymond H. ChanRaymond H. Chan
Raymond H. Chan
Chemical Exchange Saturation Transfer (CEST) MRI has demonstrated its remarkable ability to enhance the detection of macromolecules and metabolites with low concentrations. While CEST mapping is essential for quantifying molecular information, conventional methods face critical limitations: model-based approaches are constrained by limited sensitivity and robustness depending heavily on parameter setups, while data-driven deep learning methods lack generalizability across heterogeneous datasets and acquisition protocols. To overcome these challenges, we propose a Lorentzian-model Informed Neural Representation (LINR) framework for high-quality CEST mapping. LINR employs a self-supervised neural architecture embedding the Lorentzian equation – the fundamental biophysical model of CEST signal evolution – to directly reconstruct high-sensitivity parameter maps from raw z-spectra, eliminating dependency on labeled training data. Convergence of the self-supervised training strategy is guaranteed theoretically, ensuring LINR's mathematical validity. The superior performance of LINR in capturing CEST contrasts is revealed through comprehensive evaluations based on synthetic phantoms and in-vivo experiments (including tumor and Alzheimer's disease models). The intuitive parameter-free design enables adaptive integration into diverse CEST imaging workflows, positioning LINR as a versatile tool for non-invasive molecular diagnostics and pathophysiological discovery.

29 August 2025 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
YLYang Liu
Yang Liu
SPSe Weon Park
Se Weon Park
LLLok Hin Law
Lok Hin Law
KWKexin Wang
Kexin Wang
LJLicheng Ju
Licheng Ju
JHJianpan Huang
Jianpan Huang
Purpose: EPI is a fast acquisition sequence, but suffers from geometric distortion because of B 0 field inhomogeneity. This study aims to evaluate the effectiveness of using ΔB 0 map generated from single‐shot CEST‐EPI to achieve distortion self‐correction (DISC). Methods: CEST MRI usually requires B 0 correction during postprocessing, and the ΔB 0 map can be calculated directly from Z‐spectra without extra scan. We propose to use the ΔB 0 map to correct the geometry distortion induced by B 0 field inhomogeneity in CEST‐EPI. The effectiveness of DISC strategy for CEST‐EPI was evaluated on a creatine phantom, healthy and tumor mice at 3 T, and AQP4 heterozygotes mice at 11.7 T. For both the original CEST images and the generated CEST contrast maps, the spatial improvement was first confirmed by the visual comparison and then quantitatively assessed by the structural similarity index measure (SSIM) comparison together with correlation analysis. Results: DISC‐CEST‐EPI showed higher SSIM and spatial consistency compared to CEST‐EPI when using CEST‐rapid acquisition with relaxation enhancement as a reference in vitro and in vivo at 3 T. For in vivo experiments at 11.7 T, SSIM values of amide proton transfer and relayed nuclear Overhauser effects maps of DISC‐CEST‐EPI were slightly higher than CEST‐EPI and comparable with field‐mapping and top‐up. Conclusion: DISC‐CEST‐EPI can correct the distortion in CEST‐EPI at 3 T, leading to improved SSIM and CEST quantification. This approach has the potential to enhance image quality and improve diagnostic accuracy for single‐shot CEST‐EPI at especially low‐field MRI. However, the performance of DISC‐CEST‐EPI is limited at 11.7 T, and further advancements are necessary to enhance its functionality at ultra‐high fields.